RESOURCES
Working notes on clinical trial transparency since 2012 — disclosure, anonymization, and AI-assisted writing, by the people who do the work.
Artificial intelligence (AI) in healthcare was a hot topic of conversation at the recent MichBio Medical Device Summit in Ann Arbor last week. The conversation centered on AI’s…
The European clinical trials landscape is undergoing a significant transformation with the transition from EudraCT to the Clinical Trials Information System (CTIS). This shift, driven by the European…
Every year, the Drug Information Association (DIA) Annual Conference 2024 is the pinnacle event for pharmaceutical, biotechnology, and medical device professionals, and this year’s Charting News Horizon’s theme…
The Informa Clinical Data Disclosure event in Philadelphia this year brought numerous conversations on Company Confidential Information (CCI) to the forefront. For biopharmaceutical companies, protecting proprietary information and…
EMA Policy 0070 will be relaunched effective September 2023, as announced by the European Medicines Agency (EMA) during a webinar on Tuesday, May 16, 2023. Now, all Marketing…
Quantitative Risk Analysis (QRA) is a systematic approach that enables researchers to identify, evaluate, and manage risks within the clinical trial process, and clinical trials are a pivotal…
Company Confidential Information (CCI) and the need to understand what it is and what it is not, is a hotly-debated topic in the pharmaceutical industry, especially in 2023.…
The Clinical Data Disclosure, Transparency & Plain Language Summaries Conference just wrapped for 2023, bringing key decision makers in the pharmaceutical transparency space together at the Hilton at…
As the world continues to deal with the challenges created by the COVID-19 pandemic, the G7 group of nations has embarked on a G7 100-Day Mission to end…
Artificial intelligence (AI) in the pharmaceutical industry is growing as “the global artificial intelligence market size was valued at USD 136.55 billion in 2022 and is projected to…
